Aurora, IL, January 10, 2025 - Sonova is pleased to announce a leadership change in its Hearing Instruments (HI) Wholesale North America business, as Nicholai Dessypris assumed the role of President on January 1, 2025. He is succeeding Sandy Brandmeier, who retired at the end of 2024 after a distinguished six-year tenure with Sonova and over 20 years of healthcare leadership.
Nicholai Dessypris brings more than 15 years of experience in the Healthcare/MedTech and IT industries. Most recently, he served as General Manager and Vice President, North America at LifeScan. Prior to that, he held several commercial leadership roles at GE Healthcare, including Vice President of Patient Monitoring. Nicholai joined Sonova in November 2024 and has worked closely with Sandy during a transition period to ensure a seamless handover of responsibilities.
“I am honored to join Sonova and build on the strong foundation established under Sandy's leadership. Sonova’s commitment to innovation and customer centric approach inspires me, and I am thrilled to lead the North American team in advancing hearing health and delivering impactful solutions to our customers and their patients,” said Nicholai Dessypris.
Robert Woolley, Group Vice President Hearing Instruments, said: “Nicholai’s extensive experience and deep understanding of the MedTech industry and US market make him an ideal leader for this position. We are excited to see how his leadership will continue to drive growth and innovation in this key region for Sonova. We also want to extend our heartfelt gratitude to Sandy for her exceptional leadership and focus on achieving outstanding business results. Her dedication to fostering a culture of excellence has significantly contributed to Sonova's success and leaves a lasting legacy.”
About Sonova
Sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids and cochlear implants. The Group was founded in 1947 and is headquartered in Stäfa, Switzerland.
Sonova operates through four businesses – Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants – and the core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics as well as recognized regional brands. The Group’s globally diversified sales and distribution channels serve an ever growing consumer base in more than 100 countries.
In the 2023/24 financial year, the Group generated sales of CHF 3.6 billion, with a net profit of CHF 610 million. Over 18,000 employees are working on achieving Sonova’s vision of a world where everyone enjoys the delight of hearing.
For more information please visit www.sonova.com.
